Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02460497 · ClinicalTrials.gov registry record · NA

Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia

A NA study of Female Pattern Hair Loss, Androgenic Alopecia, sponsored by Galderma R&D.

Completed
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT02460497 is a NA study of Female Pattern Hair Loss, Androgenic Alopecia that has completed, run by Galderma R&D. The registered enrollment target is 61 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02460497, a NA study of Female Pattern Hair Loss, Androgenic Alopecia, has completed, sponsored by Galderma R&D.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to characterize the effect of Minoxidil 2% Solution and Botanical Hair Solution Regimen in women with thinning hair and female pattern hair loss/androgenic alopecia (Ludwig I and II).

Interventions

  • DRUG Treatment: Minoxidil 2% / Botanical Hair Solution for Women

Study Locations (1)

Texas

  • Stephens & Associates - Richardson

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2015-05-27
Est. Completion 2015-09-19
Phase NA

Sponsor

Galderma R&D

158 total trials

What the Registry Record Tells You About NCT02460497

The ClinicalTrials.gov registry entry for NCT02460497 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Female Pattern Hair Loss, Androgenic Alopecia appearing as the primary indexed condition, and to 1 intervention - of which Treatment: Minoxidil 2% / Botanical Hair Solution for Women is the first listed.

NCT02460497 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02460497 about?

NCT02460497 is a clinical study titled "Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia". The purpose of this study is to characterize the effect of Minoxidil 2% Solution and Botanical Hair Solution Regimen in women with thinning hair and female pattern hair loss/androgenic alopecia (Ludwig I and II).

What is the current status of trial NCT02460497?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2015-05-27. Estimated completion is 2015-09-19.

What conditions does trial NCT02460497 study?

This clinical trial studies the following conditions: Female Pattern Hair Loss, Androgenic Alopecia.

What interventions are being tested in trial NCT02460497?

The interventions under investigation include: Treatment: Minoxidil 2% / Botanical Hair Solution for Women (DRUG).

Who is sponsoring clinical trial NCT02460497?

This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02460497 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.